ALEXANDRIA, Va., Oct. 5 /PRNewswire/ -- Oxford Finance Corporation (Oxford), a subsidiary of Sumitomo Corporation, today announced that it is a sponsor of 2010 Mid-Atlantic Bio, which takes place October 27-29 in Bethesda, Maryland. Oxford is participating as a Life Sciences Investor Leader sponsor, and, in addition, its executives served on the committee that selects the presenting companies at the conference.
Mid-Atlantic Bio brings together industry leaders, government representatives, researchers, investors and professional services firms from around the world to promote networking, business expansion and technical-knowledge sharing.
"Oxford has proudly sponsored Mid-Atlantic Bio since its inception in 2006," said J. Alden Philbrick, president and chief executive officer of Oxford Finance Corporation. "Although this conference draws prominent leaders from all over the country, it has been especially valuable as a forum for information sharing and stimulating growth in the Mid-Atlantic region."
About Oxford Finance Corporation
A subsidiary of Sumitomo Corporation, Oxford is a specialty finance firm providing senior secured loans to public and private life science and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $1.5 billion in loans, with lines of credit ranging from $500 thousand to $40 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.
About Mid-Atlantic Bio
The Mid-Atlantic Bio Conference is co-hosted by the Tech Council of Maryland, the Mid-Atlantic Venture Association, and the Virginia Biotechnology Association. Mid-Atlantic Bio benefits from broad regional support from the investor and greater business communities, academic institutions, government agencies, and partnering regional associations. Mid-Atlantic Bio is the only globally focused, yet regionally based, event to combine components of a bioscience industry convention with an investor conference. More than 800 executives will gather to promote networking, business expansion, and technical-knowledge sharing. Home to industry-critical regulatory and research agencies; federal policymaking; and business and scientific centers of excellence, the Mid-Atlantic is a unique center for the global bioscience industry.
SOURCE Oxford Finance Corporation